Compound ID | 1254

CRS0540

Class: PolC inhibitor (thiadiazole urea derived)

Spectrum of activity: Gram-positive  &  Gram-negative
Details of activity: Gram-positive antibacterial drug.
Institute where first reported: Crestone, Inc., Boulder, United States, Colorado State University, Fort Collins, United States, SJ Brickner Consulting LLC, Ledyard, United States
Year first mentioned: 2019
Highest developmental phase: Preclinical
Development status: Active

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.